Epimorphin(-/-) Mice Are Protected, in Part, from Acute Colitis Via Decreased Interleukin 6 Signaling
Overview
Authors
Affiliations
Epimorphin (Epim), a member of the syntaxin family of membrane-bound, intracellular vesicle-docking proteins, is expressed in intestinal myofibroblasts and macrophages. We demonstrated previously that Epimorphin(-/-)(Epim(-/-)) mice are protected, in part, from dextran sodium sulfate (DSS)-induced colitis. Although interleukin (IL)-6/p-Stat3 signaling has been implicated in the pathogenesis of colitis, the myofibroblast contribution to IL-6 signaling in colitis remains unexplored. Our aim was to investigate the IL-6 pathway in Epim(-/-) mice in the DSS colitis model. Whole colonic tissue, epithelium, and stroma of WT and congenic Epim(-/-) mice treated with 5% DSS for 7 days were analyzed for IL-6 and a downstream effector, p-Stat3, by immunostaining and immunoblot. Colonic myofibroblast and peritoneal macrophage IL-6 secretion were evaluated by enzyme-linked immunosorbent assay. IL-6 and p-Stat3 expression were decreased in Epim(-/-) vs WT colon. A relative increase in stromal vs epithelial p-Stat3 expression was observed in WT mice but not in Epim(-/-) mice. Epim deletion abrogates IL-6 secretion from colonic myofibroblasts treated with IL-1β and decreases IL-6 secretion from peritoneal macrophages in a subset of DSS-treated mice. Epim deletion inhibits IL-6 secretion most profoundly from colonic myofibroblasts. Distribution of Stat3 activation is altered in DSS-treated Epim(-/-) mice. Our findings support the notion that myofibroblasts modulate IL-6/p-Stat3 signaling in DSS-treated Epim(-/-) mice.
Interleukin 6 inhibition by triptolide prevents inflammation in a mouse model of ulcerative colitis.
Zhang H, Chen W Exp Ther Med. 2017; 14(3):2271-2276.
PMID: 28962154 PMC: 5609133. DOI: 10.3892/etm.2017.4778.
Abrams J, Einhorn Z, Seiler C, Zong A, Sweeney H, Pack M Dis Model Mech. 2016; 9(5):529-40.
PMID: 26893369 PMC: 4892660. DOI: 10.1242/dmm.023309.
IKKβ in intestinal mesenchymal cells promotes initiation of colitis-associated cancer.
Koliaraki V, Pasparakis M, Kollias G J Exp Med. 2015; 212(13):2235-51.
PMID: 26621453 PMC: 4683996. DOI: 10.1084/jem.20150542.
Gargus M, Niu C, Vallone J, Binkley J, Rubin D, Shaker A Am J Physiol Gastrointest Liver Physiol. 2015; 308(11):G904-23.
PMID: 25882613 PMC: 4451324. DOI: 10.1152/ajpgi.00333.2014.